Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support

Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support

BackgroundExtracorporeal membrane oxygenation, with an inherent requirement for anticoagulation to avoid circuit thrombosis, is a key element in the treatment of respiratory failure associated with COVID-19. Anticoagulation remains challenging, the standard of care being intravenous continuous admin...

Full description

Bibliographic Details
Main Authors: Marion Wiegele, Daniel Laxar, Eva Schaden, Andreas Baierl, Mathias Maleczek, Paul Knöbl, Martina Hermann, Alexander Hermann, Christian Zauner, Johannes Gratz
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Medicine
Subjects:
acute respiratory distress syndrome
bleeding
COVID-19
enoxaparin
extracorporeal membrane oxygenation
thrombosis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.879425/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.879425/full

Similar Items